Takeaways: Nuvaxovid’s availability across 10 provinces and Yukon strengthens Sanofi’s position in Canada’s seasonal COVID-19 vaccine market by expanding access to a protein-based, non-mRN...
Takeaways: Nuvaxovid’s availability across 10 provinces and Yukon strengthens Sanofi’s position in Canada’s seasonal COVID-19 vaccine market by expanding access to a protein-based, non-mRN...